Search

Search Constraints

You searched for: Author/Creator Ghez, David

Search Results

1. Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group. Issue 6 (29th April 2017)

2. Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group. Issue 7 (11th April 2019)

3. Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO). Issue 2 (4th December 2017)

4. Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas. (6th April 2020)

5. High‐dose cyclophosphamide for hard‐to‐treat patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma, a phase II result. (28th January 2020)

6. Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy. Issue 6 (11th June 2022)

7. Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1. (6th March 2015)

9. Post-shingles granulomatous dermatosis related to anti-programmed cell death 1. (28th March 2019)

10. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. (2nd January 2017)